Erenumab For Treatment of Hemicrania Continua

Autores
Categoría Estudio primario
Registro de estudiosclinicaltrials.gov
Año 2021
Cargando información sobre las referencias
This research is being conducting to learn if the study drug erenumab is successful in treating hemicrania continua. The study is also evaluating the safety and tolerability of erenumab in individuals being treated for hemicrania continua.
Epistemonikos ID: 3f0d9b249640a534aa1857275993be93f701eada
First added on: May 07, 2024